investorscraft@gmail.com

Intrinsic ValueSoftware Service, Inc. (3733.T)

Previous Close¥12,800.00
Intrinsic Value
Upside potential
Previous Close
¥12,800.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Software Service, Inc. operates in the healthcare information services sector, specializing in electronic medical records (EMR) and hospital total ordering systems. The company serves medical institutions in Japan, leveraging its deep industry expertise since its founding in 1969. Its core revenue model is driven by software licensing, system integration, and maintenance services, ensuring recurring income streams. The firm’s solutions enhance operational efficiency for hospitals, positioning it as a trusted partner in Japan’s digitizing healthcare landscape. With no direct competitors disclosed, Software Service benefits from a niche focus on mission-critical healthcare IT infrastructure. Its long-standing presence and headquarters in Osaka reinforce regional credibility. The company’s emphasis on compliance and data security aligns with Japan’s stringent healthcare regulations, further solidifying its market position. While global EMR players exist, Software Service’s localized expertise and tailored solutions provide a competitive edge in its domestic market.

Revenue Profitability And Efficiency

For FY 2024, Software Service reported revenue of ¥38.4 billion, with net income of ¥5.3 billion, reflecting a robust net margin of approximately 13.9%. Operating cash flow stood at ¥7.2 billion, significantly exceeding capital expenditures of ¥154 million, indicating strong cash generation efficiency. The company’s capital-light model is evident in its minimal reinvestment needs relative to profitability.

Earnings Power And Capital Efficiency

The firm’s diluted EPS of ¥1,018.92 underscores its earnings strength, supported by high-margin software services. With zero debt and ¥15.3 billion in cash reserves, Software Service exhibits exceptional capital efficiency. Its ability to convert earnings into free cash flow (operating cash flow less capex) highlights disciplined financial management and low operational leverage.

Balance Sheet And Financial Health

Software Service maintains a pristine balance sheet, with no debt and substantial cash holdings equivalent to nearly 24% of its market capitalization. This liquidity position provides flexibility for strategic initiatives or shareholder returns. The absence of leverage and consistent cash generation underscore the company’s low-risk financial profile.

Growth Trends And Dividend Policy

While specific growth rates are undisclosed, the company’s focus on healthcare IT modernization aligns with sector tailwinds. A dividend of ¥130 per share suggests a payout ratio of approximately 12.8% based on EPS, indicating a conservative but sustainable distribution policy. Retained earnings likely support organic growth or future dividend increases.

Valuation And Market Expectations

At a market cap of ¥64.4 billion, the stock trades at roughly 12.1x net income, reflecting moderate valuation multiples. The low beta of 0.077 suggests minimal correlation to broader market volatility, possibly due to the defensive nature of healthcare IT demand. Investors may price in steady, rather than explosive, growth given the mature market.

Strategic Advantages And Outlook

Software Service’s entrenched position in Japan’s healthcare IT sector, coupled with its debt-free status and recurring revenue model, provides resilience. Regulatory tailwinds for EMR adoption and hospital digitization could drive incremental demand. However, growth may hinge on expanding service offerings or geographic reach beyond its current domestic focus.

Sources

Company description and financial data sourced from publicly available market data providers.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount